Skip to main content
. 2021 Apr 19;2021(4):CD013792. doi: 10.1002/14651858.CD013792.pub2

Pandian 2009.

Methods 2‐arm no treatment‐controlled randomised trial.
Participants 191 women were randomised in a hospital setting in Malaysia. The population comprised women with threatened abortion, no systematic illness or fever and no loss of conception tissue. Viability of the fetus was confirmed by ultrasound. Exclusion criteria comprised women with recurrent miscarriage (> 3), heavy bleeding, cervical polyp, multiple gestation, empty sac > 26 mm.
Interventions 40 mg oral dydrogesterone followed by 10 mg twice daily versus conservative treatment with bed rest only.
Outcomes The study recorded the following outcomes relevant for this review: live birth, miscarriage, preterm birth and congenital abnormalities.
Notes Evidence of trial documentation and data requested from the corresponding author, but no response was received by the time of publication of this review.